IFCIBSEIFCI LTD· FinanceHighNeutral
Announced Tue, 11 Aug, 2026 · 16:15 IST

IFCI Q1 FY27: Negative CRAR at minus 17.58%, Gross NPAs 95.68%

Going ConcernEmphasis Of MatterRevenue DeclineDebt Equity ThresholdContingent Liabilities IncreasedResults View source PDFExplain this filing

IFCI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.8%Reaction day
₹75.53
prior close
₹75.00
announcement price
After-mkt
timing
Nifty Smallcap 250market-0.3%-2.6% vs market
Financial Institution peers, median of 7sector-0.6%-2.2% vs sector

On the reaction day the stock moved 2.6 pts less than Nifty Smallcap 250 and 2.2 pts less than its Financial Institution peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.7
10m
-0.1
15m
-0.5
30m
-0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.8-0.3-2.6-0.6-2.2
Next day
+1.5-0.1+1.6-0.6+2.1
2d
+1.5-0.6+2.1-1.2+2.8
3d
+4.6-0.4+4.9-1.1+5.7
4d
+7.9-0.2+8.1-1.6+9.5
5d
+7.8-0.8+8.6-1.7+9.6
1w
+6.8+0.2+6.6-3.0+9.8
15d
+29.5-0.7+30.2-6.4+35.8
1m
+2.4-2.7+5.1-9.6+12.0
2m
-6.1-3.3-2.8-12.0+5.9
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Financial Institution peers, median of 7Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

IFCI reported Q1 FY27 consolidated PAT of Rs 60.27 Cr versus Rs 62.43 Cr YoY. Total income fell to Rs 327.06 Cr from Rs 407.18 Cr YoY. Standalone EPS was Rs 0.03. Major red flags: Capital Risk Adequacy Ratio (CRAR) is negative at minus 17.58%, far below RBI's required 15% minimum. Gross NPAs remain extremely elevated at 95.68% of loans. Debt-equity ratio is 2.00. Auditor flagged Emphasis of Matter on negative CRAR, IFCI group consolidation or merger plans approved in principle by the government, pending Supreme Court litigation in subsidiary, and impairment reserve treatment.

Likely market impact

Negative CRAR and 95.68% NPAs signal deep financial stress. Group merger or consolidation talks ongoing, but near-term outlook weak.